Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 485402, 12 pages
http://dx.doi.org/10.1155/2011/485402
Research Article

Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma

1Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 300-716, Republic of Korea
2Department of Herbology, College of Oriental Medicine, Sangji University, Wonju 220-702, Republic of Korea

Received 13 January 2011; Accepted 1 March 2011

Academic Editor: Steven Kunkel

Copyright © 2011 Seung-Hyung Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. A. Barrett and K. F. Austen, “Innate cells and T helper 2 cell immunity in airway inflammation,” Immunity, vol. 31, no. 3, pp. 425–437, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. Bousquet, P. Chanez, J. Y. Lacoste et al., “Eosinophilic inflammation in asthma,” The New England Journal of Medicine, vol. 323, no. 15, pp. 1033–1039, 1990. View at Google Scholar · View at Scopus
  3. H. Nakajima and K. Hirose, “Role of IL-23 and Th17 cells in airway inflammation in asthma,” Immune Network, vol. 10, no. 1, pp. 1–4, 2010. View at Google Scholar
  4. J. Zhu and W. E. Paul, “CD4 T cells: fates, functions, and faults,” Blood, vol. 112, no. 5, pp. 1557–1569, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. D. T. Umetsu and R. H. DeKruyff, “TH1 and TH2 CD4+ cells in human allergic diseases,” The Journal of Nutrition, vol. 100, no. 1, pp. 1–6, 1997. View at Google Scholar
  6. M. Wills-Karp, J. Luyimbazi, X. Xu et al., “Interleukin-13: central mediator of allergic asthma,” Science, vol. 282, no. 5397, pp. 2258–2261, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kamaraj, P. Anandakumar, S. Jagan, G. Ramakrishnan, and T. Devaki, “Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9,” European Journal of Pharmacology, vol. 649, no. 1–3, pp. 320–327, 2010. View at Google Scholar
  8. J. R. Patil, K. N. Chidambara Murthy, G. K. Jayaprakasha, M. B. Chetti, and B. S. Patil, “Bioactive compounds from mexican lime (Citrus aurantifolia) juice induce apoptosis in human pancreatic cells,” Journal of Agricultural and Food Chemistry, vol. 57, no. 22, pp. 10933–10942, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. Zielińska-Przyjemska and E. Ignatowicz, “Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism,” Phytotherapy Research, vol. 22, no. 12, pp. 1557–1562, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. H. J. Park, M. J. Kim, E. Ha, and J. H. Chung, “Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4,” Phytomedicine, vol. 15, no. 1-2, pp. 147–151, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. M. Yamamoto, A. Suzuki, and T. Hase, “Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats,” The Journal of Nutritional Science and Vitaminology, vol. 54, no. 1, pp. 95–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Kawaguchi, S. I. Kikuchi, R. Hasunuma, H. Maruyama, T. Yoshikawa, and Y. Kumazawa, “A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice,” Biological and Pharmaceutical Bulletin, vol. 27, no. 5, pp. 679–683, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Sakata, Y. Hirose, Z. Qiao, T. Tanaka, and H. Mori, “Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line,” Cancer Letters, vol. 199, no. 2, pp. 139–145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. J. Choi, J. S. Kang, J. H. Y. Park, Y. J. Lee, J. S. Choi, and Y. H. Kang, “Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells,” The Journal of Nutrition, vol. 133, no. 4, pp. 985–991, 2003. View at Google Scholar · View at Scopus
  15. J. A. Vinson, X. Liang, J. Proch, B. A. Hontz, J. Dancel, and N. Sandone, “Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease,” Advances in Experimental Medicine and Biology, vol. 505, pp. 113–122, 2002. View at Google Scholar · View at Scopus
  16. P. K. Wilmsen, D. S. Spada, and M. Salvador, “Antioxidant activity of the flavonoid hesperidin in chemical and biological systems,” Journal of Agricultural and Food Chemistry, vol. 53, no. 12, pp. 4757–4761, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. H. Chiba, M. Uehara, J. Wu et al., “Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice,” The Journal of Nutrition, vol. 133, no. 6, pp. 1892–1897, 2003. View at Google Scholar · View at Scopus
  18. Y. B. Park, K. M. Do, S. H. Bok, M. K. Lee, T. S. Jeong, and M. S. Choi, “Interactive effect of hesperidin and vitamin E supplements on cholesterol metabolism in high cholesterol-fed rats,” International Journal for Vitamin and Nutrition Research, vol. 71, no. 1, pp. 36–44, 2001. View at Google Scholar · View at Scopus
  19. H. Tanaka, T. Masuda, S. Tokuoka et al., “The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma,” Inflammation Research, vol. 50, no. 12, pp. 616–624, 2001. View at Google Scholar · View at Scopus
  20. Y. C. Lee, S. H. Kim, Y. B. Seo, S. S. Roh, and J. C. Lee, “Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma,” International Immunopharmacology, vol. 6, no. 4, pp. 703–713, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. G. Cieslewicz, A. Tomkinson, A. Adler et al., “The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration,” The Journal of Clinical Investigation, vol. 104, no. 3, pp. 301–308, 1999. View at Google Scholar · View at Scopus
  22. O. Borges, G. Borchard, A. de Sousa, H. E. Junginger, and A. Cordeiro-da-Silva, “Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers,” International Journal of Pharmaceutics, vol. 337, no. 1-2, pp. 254–264, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. Y. Lee, K. S. Ahn, OK. K. Kwon et al., “Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model,” Immunobiology, vol. 212, no. 8, pp. 647–654, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. S. S. Roh, S. H. Kim, Y. C. Lee, and Y. B. Seo, “Effects of radix adenophorae and cyclosporine A on an OVA-induced murine model of asthma by suppressing to T cells activity, eosinophilia, and bronchial hyperresponsiveness,” Mediators of Inflammation, vol. 2008, Article ID 781425, 2008. View at Publisher · View at Google Scholar · View at PubMed
  25. P. J. Barnes, “Immunology of asthma and chronic obstructive pulmonary disease,” Nature Reviews Immunology, vol. 8, no. 3, pp. 183–192, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. A. Tomkinson, C. Duez, G. Cieslewicz et al., “A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness,” Journal of Immunology, vol. 166, no. 9, pp. 5792–5800, 2001. View at Google Scholar · View at Scopus
  27. M. McKinnon, K. Page, I. J. Uings et al., “An interleukin 5 mutant distinguishes between two functional responses in human eosinophils,” The Journal of Experimental Medicine, vol. 186, no. 1, pp. 121–129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. C. J. Sanderson, “Interleukin-5, eosinophils, and disease,” Blood, vol. 79, no. 12, pp. 3101–3109, 1992. View at Google Scholar · View at Scopus
  29. J. A. MacLean, R. Ownbey, and A. D. Luster, “T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila,” The Journal of Experimental Medicine, vol. 184, no. 4, pp. 1461–1469, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. S. P. Fernández, C. Wasowski, A. C. Paladini, and M. Marder, “Synergistic interaction between hesperidin, a natural flavonoid, and diazepam,” European Journal of Pharmacology, vol. 512, no. 2-3, pp. 189–198, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. G. Kaur, N. Tirkey, and K. Chopra, “Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity,” Toxicology, vol. 226, no. 2-3, pp. 152–160, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. D. Wyss, O. Bonneau, and A. Trifilieff, “Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation,” British Journal of Pharmacology, vol. 152, no. 1, pp. 83–90, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. A. Kaplan and D. Ryan, “The role of budesonide/formoterol for maintenance and relief in the management of asthma,” Pulmonary Pharmacology and Therapeutics, vol. 23, no. 2, pp. 88–96, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. G. J. Gleich, E. Frigas, and D. A. Loegering, “Cytotoxic properties of the eosinophil major basic protein,” Journal of Immunology, vol. 123, no. 6, pp. 2925–2927, 1979. View at Google Scholar · View at Scopus
  35. S. Y. Eum, K. Maghni, Q. Hamid et al., “Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13,” The Journal of Nutrition, vol. 111, no. 5, pp. 1049–1061, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. F. Lopez, C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas, “Recombinant human interleukin 5 is a selective activator of human eosinophil function,” The Journal of Experimental Medicine, vol. 167, no. 1, pp. 219–224, 1988. View at Google Scholar · View at Scopus
  37. C. Feng, K. J. Woodside, B. A. Vance et al., “A potential role for CD69 in thymocyte emigration,” International Immunology, vol. 14, no. 6, pp. 535–544, 2002. View at Google Scholar · View at Scopus
  38. M. Kitaura, T. Nakajima, T. Imai et al., “Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3,” The Journal of Biological Chemistry, vol. 271, no. 13, pp. 7725–7730, 1996. View at Publisher · View at Google Scholar · View at Scopus
  39. S. P. Umland, Y. Wan, J. Shortall et al., “Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells,” Journal of Leukocyte Biology, vol. 67, no. 3, pp. 441–447, 2000. View at Google Scholar · View at Scopus
  40. M. E. Rothenberg, A. D. Luster, and P. Leder, “Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 19, pp. 8960–8964, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. P. H. S. Sporn, F. P. Fries, and J. A. Anderson, “Eotaxin enhances synthesis of leukotriene C4 synthesis by human blood eosinophils [abstract],” American Journal of Respiratory and Critical Care Medicine, vol. 161, p. A709, 2000. View at Google Scholar
  42. M. E. Rothenberg, J. A. MacLean, E. Pearlman, A. D. Luster, and P. Leder, “Targeted disruption of the chemokine eotaxin partially reduces antigen- induced tissue eosinophilia,” The Journal of Experimental Medicine, vol. 185, no. 4, pp. 785–790, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. J. A. Gonzalo, C. M. Lloyd, L. Kremer et al., “Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells, chemokines, and adhesion receptors,” The Journal of Clinical Investigation, vol. 98, no. 10, pp. 2332–2345, 1996. View at Google Scholar · View at Scopus
  44. L. L. Zhao, J. Lotvall, A. Linden, M. Tomaki, M. Sjostrand, and A. Bossios, “Prolonged eosinophil production after allergen exposure in IFNgammaR KO mice is IL-5 dependent,” Scandinavian Journal of Immunology, vol. 67, pp. 480–488, 2009. View at Google Scholar
  45. O. Prause, A. Bossios, E. Silverpil et al., “IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar spaceafter exposure to endotoxin from Escherichia coli in vivo—effects of anti-inflammatory pharmacotherapy,” Pulmonary Pharmacology and Therapeutics, vol. 22, no. 3, pp. 199–207, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. H. Wakashin, K. Hirose, Y. Maezawa et al., “IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice,” American Journal of Respiratory and Critical Care Medicine, vol. 178, no. 10, pp. 1023–1032, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. W. Ouyang, S. H. Ranganath, K. Weindel et al., “Inhibition of Th1 development mediated by GATA-3 through an IL-4- independent mechanism,” Immunity, vol. 9, no. 5, pp. 745–755, 1998. View at Google Scholar · View at Scopus
  48. L. H. Glimcher and K. M. Murphy, “Lineage commitment in the immune system: the T helper lymphocyte grows up,” Genes and Development, vol. 14, no. 14, pp. 1693–1711, 2000. View at Google Scholar · View at Scopus
  49. M. F. Neurath, S. Finotto, and L. H. Glimcher, “The role of TH1/TH2 polarization in mucosal immunity,” Nature Medicine, vol. 8, no. 6, pp. 567–573, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. T. Kiwamoto, Y. Ishii, Y. Morishima et al., “Transcription factors T-bet and GATA-3 regulate development of airway remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 2, pp. 142–151, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus